Liver transplants work. They really do. But there isn’t enough supply for the demand.
There are other problems too. The drugs patients need to keep from rejecting the organ, they aren’t free of side effects. They require a lifetime commitment. Scientists want a better way. One that bypasses the scarcity issue. One that doesn’t force someone to poison their body to save it.
Hepatocyte transplantation sounds like a good plan. You inject liver cells directly into the patient. The problem? Most of them die. Or worse. The body rejects them.
They have low “engraftment efficiency.” Fancy speak for not sticking around long enough to help.
It’s a tough path. But researchers at Tongji University in Shanghai dug into why this happens. Ting Fang and his team wanted to know how mature liver cells switch from doing their normal job to suddenly trying to rebuild a wrecked organ.
Understanding donor hepatocyte proliferation biology is key
The goal is clear. Make those transplanted cells grow faster. Make them regenerate tissue. Keep the liver working while it heals.
Glowing Cells and Broken Mice
How do you study cells that multiply only when the liver is hurting?
You give them a spotlight.
Fang’s team tagged donor hepatocytes with fluorescent proteins. These markers make the cells glow under a microscope. Easy to track.
They put these glowing cells into mice. Specifically mice with the Fah-/- gene defect. It’s a standard model for studying acute liver failure in humans.
Then they waited. And watched.
A week after the transplant. The glowing cells looked different at the genetic level. They had changed their song. Their gene expression profile shifted entirely.
By week 12? It all snapped back.
The cells settled into a normal rhythm. But that middle period—when the cells were frantic and reproducing—is where the secret lies. The researchers noticed something specific during this phase. These temporary, hardworking cells overexpressed a gene called AFT (Alpha-fetoprotein).
So they named them: Afp⁺ rHep. Short for Afp-positive reprogrammed hepatocytes.
Transplanted mature hepatocytes undergo extensive转录al remodeling… generating a transient subpopulation
They are fleeting. They do their job. Then they go back to being boring, adult cells.
Not Just Copy-Pasting Growth
You might think these cells were just reverting to a baby stage. Like dedifferentiation. Going backward to divide more easily.
It’s not that simple.
Fang’s group compared the Afp⁺ rHaps against a genetic atlas of liver development. Normal immature cells have certain genes active. These transplanted ones didn’t look exactly like them.
These reprogrammed adult cells did something smarter. They activated genes for proliferation. But they kept the genes for metabolism running. They could divide. And they could still process chemicals.
Most growing cells can’t do both. This is a coordinated effort. A balancing act between making new parts and keeping the engine running.
The team looked at what proteins interact with the AFP protein. They used co-immunoprecipitation and mass spectrometry. Old-school heavy lifting for molecular biology.
They found AFP talking to PPARγ. That stands for Peroxisome Proliferator-Activated Receptor gamma.
PPARγ is huge. It regulates metabolic function in liver cells. So AFP isn’t just a marker for growth. It’s the traffic controller linking growth to metabolism.
But this is just mice. Humans are complicated. Do they share this mechanism?
Fang checked public genetic datasets. They looked at patients who suffered acute liver failure from acetaminophen overdoses. Or viral hepatitis.
The same genes lit up in those people.
This conservation underscores the translational relevance
Same signal. Same repair strategy. In mice. In humans.
The Trigger
So how does it start? Why does a healthy adult liver cell decide it wants to act like a builder for two weeks?
The environment.
Cells live in a microenvironment. They feel what’s happening around them.
The researchers looked at immune responses in the injured liver. They found the trigger was an inflammatory signal called TNF-α.
Not IL-6. Not the usual suspects.
TNF-α does it.
But where did that TNF-α come from? They hunted the source. It turned out to be neutrophils. Immune cells rushing to the scene of the damage.
The sequence looks like this.
The liver gets damaged. Neutrophils show up. They dump TNF-α into the mix. The transplanted hepatocytes catch that signal.
It flips a switch. AFP goes high. PPARγ gets involved. The cells stop resting and start multiplying.
They enter the proliferative state. They help rebuild the liver. Then they stop.
A Better Selection Process
Current selection for transplant cells relies on old markers. Things we already know about.
This study suggests we need a new list.
Instead of picking any cell. Or just healthy-looking cells. Why not pick the ones most likely to regenerate?
If you know that AFP expression predicts a cell’s ability to enter this “builder” state, you can select for those specifically. You choose cells with both metabolic fitness and reproductive drive.
It changes how we prep the material for transplantation.
These findings advance a functionally- validated model
The framework is here. The targets are identified. The pathway from neutrophil inflammation to AFP-driven regeneration is mapped out.
Next steps? Clinical studies. Testing it on real people.
Right now we have a mechanism. A clear link between the immune system’s first response and the liver’s repair kit.
It makes you wonder if we’ve been looking at donor cells wrong all this time.
Or if the key was sitting in plain sight inside the immune cells all along.
Reference: T. Fang et al., Conversion of Transplanted Mautrue Hepatocytes into Afp⁺ Reprogrammed Cells for Liver regeneration after injury. Advanced Science (202). DOI: 10.102/advs.225711
